Formerly About Advanced Micro Devices Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RetiredNow who wrote (1100836)	11/21/2018 1:48:36 PM
From: Tenchusatsu	1 Recommendation Recommended By RetiredNow Read Replies (2) of 1583269

Mindmeld, speaking of stories that you'll never see on CNNTimesPost, here's something the WSJ OpEd is calling out. Gee, I wonder why the Obama administration was so slow to approve of generics. Could be because they wanted to push a political narrative? Tenchusatsu Sticking it to Pharma—With Competition The FDA has over 20 months of the Trump Administration approved an astounding 1,617 generic drugs, which are identical to branded versions but sold at commodity prices after patents expire. That works out to 81 a month on average—an 17% increase over the preceding 20 months. The Council of Economic Advisers in October tried to tally the savings from new entrants: $26 billion. What’s remarkable is that FDA is speeding up even as fewer patents are expiring. *The reason is Commissioner Scott Gottlieb’s prescriptions: clearing out an application backlog, putting priority on drugs where competition is limited, and more.* The market for generics can respond to policy changes with some speed because copying a drug is much less onerous than new drug discovery and approval.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next